MoneyWorks4Me

Sun Pharmaceutical Industries informs about press release

28 Sep 2026 Evaluate
Sun Pharmaceutical Industries has informed that it enclosed copy of the press release titled ‘LIB Therapeutics and Sun Pharma Announce Global Licensing, Commercialization and Manufacturing Agreement for Lerodalcibep, a PCSK9 Inhibitor, Ex-US and China; Lyrokaul (lerodalcibep) Approved in the EU’ which shall be released after this intimation.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1222.50
Cipla 1388.90
Lupin 2061.85
Zydus Lifesciences 1212.00
View more..